Prostate Cancer Prevention Trial (PCPT) and Finasteride

Hi Dr Rassman, have you seen the latest findings on the prostate cancer prevention trials? The current info seems like good new for finasteride users.

see link — Finasteride Reduces the Risk of Low-Grade Prostate Cancer in Men 55 and Older

Yes, this is a consistent finding by the government sponsored studies.

Here’s the summary:

“Long-term follow-up results from a phase III trial called the Prostate Cancer Prevention Trial (PCPT) continue to show that regular use of finasteride (Proscar®) for up to 7 years decreased the risk of low-grade prostate cancer in men age 55 and older compared with that in men who received a placebo. Although high-grade cancers were more common in the finasteride group, the finasteride and placebo groups had similar 15-year overall survival rates.”